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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S142Purpose: Osteoarthrtitis (OA) is a chronic low-grade inﬂammatory
disease for which the diagnosis currently relies on clinical and radio-
logical means whereas sensitive serum biomarkers speciﬁc for an early
stage of the disease are lacking. The aim of the study was to identify
speciﬁc molecular alterations of articular cartilage in an in vitro
inﬂammation model. The pro-inﬂammatory cytokine interleukin (IL)-
1b was used to induce degradation of articular cartilage explants cul-
tured in vitro with the purpose of mimicking OA cartilage in early and
later developmental stages. The speciﬁc objective was to longitudinally
characterize and quantify the release of cartilage matrix components to
the media by using a quantitative proteomic approach.
Methods: Full thickness equine articular cartilage explants were har-
vested from the weight bearing part of the distal metacarpal bone III in
the metacarpal-phalangeal joint of three horses. The explants were
cultured in the presence or absence of interleukin IL-1b in-vitro and cell
mediawas changed and sampled at day 3, 6, 9,12,15,18 and 22. Proteins
were isolated from the harvested media and following tryptic digestion
the peptides were labeled with isobaric tandem mass tags (TMT) and
analyzed by liquid chromatography-mass spectrometry (LC-MS/MS).
The TMT reporter ion intensities in MS/MS spectra were divided by
reference reporter ion intensities, giving a relative amount for each
quantiﬁed peptide. The relative amount of released components in
media from IL-1b stimulated and unstimulated explants were com-
pared over time.
Results: IL-1b stimulation resulted in an abundance of proteins related
to the extra cellular matrix and the proteins were released at different
time points during culturing time. Release of several cartilage matrix
components e.g. aggrecan, cartilage oligomeric matrix protein (COMP),
chondroadherin, thrombospondin-1 and proteoglycan 4 displayed high
amounts at days 3 and 6, similar to the early stage of the disease process
of OA in vivo. Collagen type XII release was identiﬁed at day 9 and 12
and the release of collagen type VI increased continually from day 18-
22. Several small leucine-rich proteoglycans (SLRP) such as biglycan and
lumican had the highest release at day 22, together with a high amount
of collagen type II in IL-1b stimulated media. The unstimulated media
showed signs of new synthesis of collagen type II, by the presence of
high amount of procollagen type II C-propeptide and C endopeptidase
enhancers, and this collagen synthesis was not at all prominent in the
IL-1b stimulated media.
Conclusions: This inﬂammatory in vitro model display structural
changes seen at distinct developmental stages of OA in vivo. Novel
ﬁndings presented are the release, at different time points after IL-1b
stimulation, of cartilage components in a speciﬁc time pattern in the
order as follows; COMP, collagen type XII, collagen type VI, SLRPs and
ﬁnally collagen type II, indicating a degradation of the collagen network
in a distinct pattern, without evidence for new synthesis of collagen
type II. The results from the unstimulated explants indicate repair
capacity with an increase of collagen synthesis. The identiﬁcation of
early biochemical changes in cartilage would be of great importance in
both ﬁnding diseasemodifying pharmaceutical compounds aswell as in
the development of biomarkers for early OA.
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IMMUNOHISTOCHEMICAL LOCALIZATION OF NOTCH SIGNALING
COMPONENTS, MATRIX COMPONENTS AND STRO-1 IN PRENATAL,
POSTNATAL AND OSTEOARTHRITIC EQUINE CARTILAGE
M. L€ofgren y, S. Ekman y, C. Ley y, A. Lindahl z, E. Svala y,z,
E. Ski€oldebrand y,z. , Major contributor: late Professor Dick
HeinegardyDept. of BioMed. Sci. and Vet. Publ. Hlth., Swedish Univ. of
Agricultural Sci., Uppsala, Sweden; zDept. of Clinical Chemistry and
Transfusion Med., Inst. of Biomedicine, Sahlgrenska Univ. Hosp.,
Gothenburg Univ., Gothenburg, Sweden
Purpose: The growth plate and articular cartilage of developing syno-
vial joints include speciﬁc zones of chondrocytes with different phe-
notypes. The chondrocytes in the growth plate change from resting to
proliferative and hypertrophic phenotypes. Phenotypical changes also
occur in the chondrocytes of the articular cartilage during the pro-
gression of osteoarthritis (OA). The expression of proteins on the
chondrocytes as well as in the surrounding matrix affects the pheno-
type and can be used to characterize cells of speciﬁc phenotypes.
The aim of the study was to localize components with potential effects
on the phenotype such as the Notch signaling components including
the receptor Notch1, the ligand Delta4 and the target gene Hes1.
Additionally the stem cell indicating marker Stro-1 and matrixmolecules were localized to further characterize cells and matrix in
developing prenatal and postnatal equine cartilage as well as in OA
cartilage.
Methods: Immature equine osteochondral tissues, representing dif-
ferent developmental stages of the articular and growth cartilage of the
distal radius were collected post mortem from two fetuses (6.5 and 10
months gestational age) and from two young horses (2-day-old and 1-
year-old). Articular cartilage from fetlock joints of adult horses was
collected and articular cartilage with superﬁcial chondronecrosis,
ﬁbrillation and adjacent cluster formations, compatible with OA carti-
lage was identiﬁed by histology and included in the study. The local-
ization of Notch signaling components, Stro-1 and the matrix molecules
cartilage oligomeric matrix protein (COMP), ﬁbromodulin, chon-
droadherin and matrilin-1 was examined by immunohistochemistry.
Results: Notch1, Delta4 and Hes1 indicating active Notch signaling was
localized in hypertrophic cells in growth plates of the distal radius in all
horses, as well as in resting cells of prenatal horses and in proliferative
cells of the youngest fetus. The same proteins were present in all zones
of the radial articular cartilage of the postnatal horses, whereas only a
few cells were stained in the youngest fetus.
Stro-1 was present in the resting zone of the youngest fetus, with weak
immunolabeling in the resting zone of the 10-month-old fetus and only
detected as weak immunolabeling in the proliferative zone of the 2-
day-old horse and not detected in the growth plate of the 1-year-old
horse. In articular cartilage the chondrocytes stained positive for Stro-1
in all zones of the youngest fetus, whereas the staining became
restricted to the superﬁcial and middle zones in the postnatal horses.
Most matrix molecules gradually changed in location with increasing
age from interterritorial to pericellular location in the growth plates. The
most prominent changes were observed in the hypertrophic zone where
COMP, ﬁbromodulin and chondroadherin were localized interterrito-
rially in the prenatal horses but shifted to a pericellular location in the
postnatal horses. Matrilin-1 was present in the hypertrophic zone of the
prenatal horses but absent in the postnatal horses. In the articular car-
tilage thematrix molecules were present in all zones with an age related
shift from interterritorial to pericellular location in all zones but the
superﬁcial zone, which displayed interterritorial staining in all horses.
The Notch1 receptor and the Delta4 ligand were detected in all zones of
OA cartilage with the strongest staining in the superﬁcial zone and in
cell clusters. Intense Stro-1 and weak Hes1 immunolabeling was
detected in the superﬁcial zone and in cell clusters. All matrix compo-
nents were present in OA cartilage.
Conclusions: This study demonstrates presence of Notch signaling
components in equine cartilage of different developmental stages
which support previous ﬁndings of a role for Notch signaling in endo-
chondral ossiﬁcation and differentiation of chondrocytes. The studied
matrix molecules known to be involved in the formation and organ-
ization of the collagen network showed age related differences in
localization of the molecules, which may indicate increased mechanical
load or altered expression related to different developmental stages.
The weak staining of Hes1 in OA cartilage suggests low activity of the
Notch1 signaling, and the strong staining of Stro-1 in the superﬁcial
zone and OA cell clusters indicates stem cell like characteristics of the
chondrocytes. This is the ﬁrst study demonstrating the localization of
Notch signaling components, Stro-1 and matrix components in equine
growth cartilage of different developmental stages and OA cartilage.
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OSTEOCLASTS REDUCE THE ACTIVATION OF WNT CANONICAL
PATHWAY IN CHONDROCYTES
C. Cheriﬁ, W. Bouaziz, M. Cohen-Solal, E. Hay. Inserm U1132, Paris,
France
Purpose: Osteoclastogenesis is enhanced in early osteoarthritis (OA).
We have previously demonstrated that cartilage degradation is reduced
in vivo when osteoclastogenesis is inhibited in murine models with
high bone resorption. Wnt activity, known to regulate the bone and
chondrocyte cell function, might contribute to the mechanisms that
promote cartilage breakdown. Our purpose was to evaluate whether
osteoclast-secreting molecules affect directly the metabolism of chon-
drocyte and the contribution of Wnt pathway.
Methods: Osteoclasts were obtained after differentiation of RAW cells
cultured with RANKL. Primary murine chondrocyte (Ch) were then
cultured in the presence of osteoclast conditioned medium (Oc-CM) for
48h. The gene and protein expressions of catabolism and anabolism
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lation of canonical Wnt pathway, transactivation assay was performed
in primary chondrocytes derived from Topgal mice and cultured with
Oc-CM. Western blot and immunocytochemistry were used to conﬁrm
the activation of b-catenin canonical Wnt signaling pathway. Finally, in
order to conﬁrm the role of Wnt canonical signaling, the b-catenin
translocation was activated with the addition of lithium chloride (LiCl)
in the Oc-CM.
Results: Oc-CM induced a marked decrease in proteoglycan release by
chondrocytes. This is the result of both the reduction of the expression
of anabolic genes such as collagen type II, Aggrecan and Sox-9 and the
increase of the expression of catabolic genes such as metalloproteases
(MMP-3 and -13) and aggrecanases (Adamts-4 and-5). We then moni-
tored the nuclear translocation of b-catenin induced by Oc-CM. We
observed an abolition of the translocation of b-catenin and sub-
sequently of Topgal activity along with the reduction of Wnt target
genes (Axin, Wisp1 C-Myc). In order to rescue the inhibition of can-
onical pathway induced by Oc-CM, a dose-effect of LiCl was performed
(1 - 5 mM). Low dose of LiCl totally reversed the effect of Oc-CM while
was aggravated with the highest dose.
Conclusion: We here demonstrated that osteoclasts secrete soluble
factors able to disrupt the balance of chondrocyte metabolism via the
inhibition of theWnt canonical signaling. Therefore, manipulating bone
may affect chondrocyte function.
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GALECTIN FINGERPRINTING IN OA CARTILAGE
S. Toegel y, D. Bieder y, S.M. Walzer y, S. Andre z, H. Kaltner z,
H.-J. Gabius z, K. Kayser x, R. Windhager y. yKarl Chiari Lab for
Orthopaedic Biology, Dept. of Orthopaedics, Med. Univ. of Vienna,
Vienna, Australia; z Inst. of Physiological Chemistry, Faculty of Vet. Med.,
Ludwig-Maximilians-Univ. Munich, Munich, Germany; x Inst. of
Pathology, Charite, Berlin, Germany
Purpose: Enormous amounts of biological information are triggered by
the interaction between glycans and their endogenous receptors (e.g.,
galectins). However, the potential implications of ‘cartilage glycobiol-
ogy in the pathophysiology of osteoarthritis (OA) remain largely
unknown. We recently showed that interleukin-1beta and tumor
necrosis factor-alpha can alter distinct aspects of the glycan pattern of
cultured human chondrocytes, such as the status and type of N glycan
sialylation. Notably, glycan structures of OA chondrocytes are not only
altered in vitro but also in situ with progressing cartilage degeneration.
Addressing the protein part of the galectin-glycan recognition system,
the present study was designed to assess the expression and local-
ization of endogenous galectins (Gal-1, Gal-2, Gal-3, Gal-4, Gal-7, Gal-8,
Gal-9) in human OA and non-OA cartilage.
Methods: OA cartilage was received from total knee replacement sur-
geries, whereas non-OA cartilage was obtained from osteosarcoma
patients. OA chondrocytes were isolated and cultured as monolayers.
Galectin expression in cultured chondrocytes was determined at the
mRNA level using validated RT-qPCR assays (for LGALS1, -2, -3, -4, -7, -8,
-9) and at the protein level using immunocytochemistry. Cartilage tis-
sues were processed for histology and immunohistochemistry. The
degeneration status of the tissues was assessed using the Mankin score
(MS), based on Safranin O staining. Immunohistochemistry and multi-
color immunoﬂuorescence staining for galectins was performed on
cartilage sections using a panel of non-crossreactive antibodies. The
number of stained cells was assessed microscopically whereas the
staining intensity was evaluated histomorphometrically.
Results: Among all evaluated galectins, cultured OA chondrocytes
predominantly expressed LGALS1 and LGALS3 mRNA and, corre-
spondingly, Gal-1 and Gal-3. In agreement, sections of OA cartilage
presented predominant staining for Gal-1 and Gal-3. Using multicolor
immunolabeling of OA cartilage tissues, Gal-1 and Gal-3 were shown to
co-localize in complex chondrons of regions of advanced degeneration.
Importantly, we found that the number of positive chondrocytes was
signiﬁcantly higher in regions of advanced cartilage degeneration
(MS9) as compared to areas of mild degeneration (MS4) in case of all
evaluated galectins (n ¼ 10 patients; p < 0.001; paired t-test). Mor-
phometric analysis revealed that the fraction of moderately stained
chondrocytes for Gal-1 signiﬁcantly increased 4-fold in regions of
advanced cartilage degeneration (MS9), whereas the fraction of
weakly stained cells signiﬁcantly decreased (n ¼ 7 patients; p < 0.01;
paired t-test). Assessment using quick scoring, that combined the visualassessment of both the number of stained cells and their staining
intensity, revealed signiﬁcantly increased scores for Gal-1, Gal-3 and
Gal-8 in regions of advanced cartilage degeneration (n ¼ 10 patients; p
< 0.01; paired t-test). In contrast to OA cartilage sections, galectin
staining was absent in chondrocytes of non-OA specimens (n ¼ 4).
Conclusions: In summary, this study deﬁnes the presence and local-
ization of endogenous galectins in OA cartilage and chondrocytes. In
addition, it reports the increasing occurrence of galectins - in particular
of Gal-1 and Gal-3 - in cartilage regions of advanced degeneration. This
gives further work on ‘cartilage glycobiology’ a clear direction: deﬁning
the molecular mechanisms underlying galectin-overexpression in OA
and in vitro testing of galectins in relevant cell models to reveal their
biological activities and target glycoproteins.
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PALMITATE HAS PROAPOPTOTIC AND PROINFLAMMATORY EFFECTS
ON ARTICULAR CARTILAGE AND SYNERGIZES WITH INTERLEUKIN-1.
O. Alvarez-Garcia y, N.H. Rogers z, R.G. Smith x, M.K. Lotz y. y The Scripps
Res. Inst., La Jolla, CA, USA; zCalifornia Inst. for BioMed. Res., La Jolla, CA,
USA; x The Scripps Res. Inst., Jupiter, FL, USA
Purpose: Obesity is a major risk factor for the development of
osteoarthritis (OA) that is associated with a state of low-grade
inﬂammation, and increased circulating adipokines and free fatty
acids (FFA). The aim of this study was to analyze effects of saturated
(palmitate) and monounsaturated (oleate) FFAs on articular cartilage
and chondrocytes.
Methods: Human Articular Chondrocytes (hAC) obtained from young
healthy donors (223 years) or OA donors undergoing knee replace-
ment surgery (569 years) were grown in monolayer cultures until
conﬂuence. For cell viability and caspase 3/7 activation assays, hACwere
treated with 0.5 mM palmitate, 0.5 mM oleate or vehicle, in the pres-
ence or absence of 1 ng/ml IL-1b for 72 hours. For gene expression
studies, shorter treatment time (24-hours) and lower IL-1b concen-
tration (10 pg/ml) were used. Expression levels of proinﬂammatory
factors, extracellular matrix proteins and extracellular proteases were
measured. In addition, chondrocyte viability and matrix damage were
assessed in bovine articular cartilage explants cultured with FFAwith or
without IL-1b.
Results: Palmitate induced caspase 3/7 activation and cell death in IL-
1b -stimulated normal hAC, and upregulated il6 and cox2 expression
through toll-like receptor-4 (TLR-4) signaling. Palmitate proin-
ﬂammatory and proapoptotic effects were synergistically increased
upon IL-1b co-treatment. Exposure to FFAs did not modify type II col-
lagen, aggrecan, ADAMTS-4, -5, and MMP13 gene expression after 24
hours. Ex vivo experiments in bovine cartilage explants showed that
palmitate accelerated cartilage destruction driven by IL-1b, as evi-
denced by a signiﬁcant increase in cell death and glycosaminoglycan
release. Lastly, pharmacological inhibition of caspases and TLR4 sig-
nalling signiﬁcantly reduced palmitate and IL-1b-induced cartilage
damage.
Conclusions: Palmitate acts as a pro-inﬂammatory and catabolic factor
that, in synergy with IL-1b, induces chondrocyte apoptosis and articular
cartilage breakdown. Collectively, our data suggest that elevated levels
of saturated FFA often found in obesity may contribute to OA patho-
genesis.
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THREE NEW FUNCTIONALLY CONSERVED CIS-REGULATORY
ELEMENTS IN THE ACAN GENE
G. Bou-Gharios y, K. Liu y, I. Li y, S. De Val z. yUniv. of Liverpool, Liverpool,
United Kingdom; zUniv. of Oxford, Oxford, United Kingdom
Purpose: Aggrecan gene (Acan) codes for the chondroitin sulfate pro-
teoglycan, a key core protein responsible for the unique mechanical
properties of cartilage. Aggrecan protein is required both for proper
cartilage formation in development and maintenance of mature carti-
lage as illustrated by the phenotypes of chicken and mouse mutants.
The transcriptional regulation of this important gene is not fully
understood. This investigation was undertaken to shed light on the cis-
acting sequences that deﬁne the Acan expression in skeletal elements
Methods: The expression of Acan in cartilage is highly conserved in
evolution, and has been described in Xenopus and zebraﬁsh as well as
chicken, mouse, and other mammals.
